Insider Transactions in Q2 2021 at Eloxx Pharmaceuticals, Inc. (ELOX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
May 25 2021	Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC	SELL Payment of exercise price or tax liability	Direct	1,835 -5.49%	$1,835 $1.39 P/Share
May 25 2021	Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC	BUY Exercise of conversion of derivative security	Direct	6,250 +15.75%	-
May 13 2021	Tomer Kariv Director	BUY Open market or private purchase	Indirect	5,925,925 +43.52%	$5,925,925 $1.35 P/Share
May 13 2021	Ran Nussbaum Director	BUY Open market or private purchase	Indirect	5,925,925 +43.52%	$5,925,925 $1.35 P/Share
May 13 2021	Pontifax Management 4 G.P. (2015) Ltd. > 10% Shareholder	BUY Open market or private purchase	Indirect	5,925,925 +43.52%	$5,925,925 $1.35 P/Share
May 13 2021	Rajesh B Parekh Director	BUY Open market or private purchase	Indirect	2,466,666 +33.04%	$2,466,666 $1.35 P/Share
Apr 30 2021	Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC	SELL Payment of exercise price or tax liability	Direct	459 -1.66%	$918 $2.18 P/Share
Apr 30 2021	Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC	BUY Exercise of conversion of derivative security	Direct	1,562 +5.35%	-
Apr 01 2021	Rajesh B Parekh Director	BUY Grant, award, or other acquisition	Indirect	2,532,270 +50.0%	-

Receive a notification when an Institution or Guru buys or sells ELOX shares.

Notify only if

Value

Get notified when an Eloxx Pharmaceuticals, Inc. insider buys or sells ELOX shares.

Notify only if

Operation

Value

Type

Receive news related to Eloxx Pharmaceuticals, Inc.